Immunogenicity of constitutively active V599EBRaf
Activating BRAF somatic missense mutations within the kinase domain are present in 60-66% of melanomas. The vast majority of these represent a single substitution of glutamate for valine (V599E). Here, we demonstrate spontaneous HLA-B*2705-restricted cytotoxic T-cell responses against an epitope der...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 2, 2004
|
| In: |
Cancer research
Year: 2004, Jahrgang: 64, Heft: 15, Pages: 5456-5460 |
| ISSN: | 1538-7445 |
| DOI: | 10.1158/0008-5472.CAN-04-0937 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/0008-5472.CAN-04-0937 Verlag, lizenzpflichtig, Volltext: https://cancerres.aacrjournals.org/content/64/15/5456 |
| Verfasserangaben: | Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1742485235 | ||
| 003 | DE-627 | ||
| 005 | 20220819051357.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201210s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/0008-5472.CAN-04-0937 |2 doi | |
| 035 | |a (DE-627)1742485235 | ||
| 035 | |a (DE-599)KXP1742485235 | ||
| 035 | |a (OCoLC)1341383379 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Andersen, Mads Hald |e VerfasserIn |0 (DE-588)122312181X |0 (DE-627)1742485928 |4 aut | |
| 245 | 1 | 0 | |a Immunogenicity of constitutively active V599EBRaf |c Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker |
| 246 | 3 | 3 | |a Immunogenicity of constitutively active V599E BRaf |
| 264 | 1 | |c August 2, 2004 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.12.2020 | ||
| 500 | |a Im Titel ist der Ausdruck "V599E" hochgestellt | ||
| 520 | |a Activating BRAF somatic missense mutations within the kinase domain are present in 60-66% of melanomas. The vast majority of these represent a single substitution of glutamate for valine (V599E). Here, we demonstrate spontaneous HLA-B*2705-restricted cytotoxic T-cell responses against an epitope derived from V599EBRaf. These T-cell responses were mutation specific as the corresponding epitope derived from wild-type BRaf was not recognized. The loss of the V599EBRAF genotype during progression from primary to metastatic melanoma in patients with V599EBRaf specific T-cell responses suggests an active immune selection of nonmutated melanoma clones by the tumor-bearing host. | ||
| 700 | 1 | |a Ugurel, Selma |d 1971- |e VerfasserIn |0 (DE-588)122030923 |0 (DE-627)081693532 |0 (DE-576)293057567 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer research |d Philadelphia, Pa. : AACR, 1941 |g 64(2004), 15, Seite 5456-5460 |h Online-Ressource |w (DE-627)325489955 |w (DE-600)2036785-5 |w (DE-576)094502226 |x 1538-7445 |7 nnas |a Immunogenicity of constitutively active V599EBRaf |
| 773 | 1 | 8 | |g volume:64 |g year:2004 |g number:15 |g pages:5456-5460 |g extent:5 |a Immunogenicity of constitutively active V599EBRaf |
| 856 | 4 | 0 | |u https://doi.org/10.1158/0008-5472.CAN-04-0937 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://cancerres.aacrjournals.org/content/64/15/5456 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201210 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 8 | ||
| 998 | |g 122030923 |a Ugurel, Selma |m 122030923:Ugurel, Selma |d 910000 |d 950000 |d 950950 |e 910000PU122030923 |e 950000PU122030923 |e 950950PU122030923 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 3 | ||
| 999 | |a KXP-PPN1742485235 |e 3822458775 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"5 S."}],"id":{"eki":["1742485235"],"doi":["10.1158/0008-5472.CAN-04-0937"]},"name":{"displayForm":["Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker"]},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"August 2, 2004"}],"relHost":[{"id":{"zdb":["2036785-5"],"eki":["325489955"],"issn":["1538-7445"]},"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"name":{"displayForm":["American Association for Cancer Research"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedKey":"1941","publisher":"AACR","dateIssuedDisp":"1941-"}],"note":["Gesehen am 31.03.25","Fortsetzung der Druck-Ausgabe"],"title":[{"title_sort":"Cancer research","title":"Cancer research"}],"language":["eng"],"pubHistory":["Volume 1, issue 1 (1 January 1941)-"],"recId":"325489955","part":{"extent":"5","year":"2004","pages":"5456-5460","text":"64(2004), 15, Seite 5456-5460","issue":"15","volume":"64"},"disp":"Immunogenicity of constitutively active V599EBRafCancer research"}],"recId":"1742485235","language":["eng"],"title":[{"title":"Immunogenicity of constitutively active V599EBRaf","title_sort":"Immunogenicity of constitutively active V599EBRaf"}],"note":["Gesehen am 10.12.2020","Im Titel ist der Ausdruck \"V599E\" hochgestellt"],"titleAlt":[{"title":"Immunogenicity of constitutively active V599E BRaf"}],"person":[{"role":"aut","given":"Mads Hald","display":"Andersen, Mads Hald","family":"Andersen"},{"role":"aut","given":"Selma","display":"Ugurel, Selma","family":"Ugurel"},{"role":"aut","given":"Dirk","display":"Schadendorf, Dirk","family":"Schadendorf"}]} | ||
| SRT | |a ANDERSENMAIMMUNOGENI2200 | ||